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ABSTRACT
Objectives: Neuropathic cough that
is incompletely responsive to medical
therapy may be due to
cricopharyngeal hypertonicity. The
objective was to describe the utility of
cricopharyngeal myotomy in
alleviating symptoms of intractable
neuropathic cough.
Study Design: Retrospective review.
Methods: A retrospective chart
review was performed for three
patients who underwent
cricopharyngeal myotomy for
intractable cough. Trigger
phenomena, previous evaluation and
treatment, and outcomes after
surgery, namely patient perception of
improvement and medication use
after surgery, were assessed and
documented.
Results: After cricopharyngeal
myotomy, all three patients noted
symptomatic improvement and were
weaned off medication. Continued
improvement was noted at follow up,
with a mean length of 22 months
(range: 7-36 months).
Conclusions: Cricopharyngeal
myotomy may be an alternative
treatment for chronic cough in
patients for whom workup is negative
and medical management, dilation,
and botulinum toxin have failed to
provide long-term relief.

INTRODUCTION
Chronic cough is a challenging
diagnostic and therapeutic entity due to its
multiple etiologies. For patients whose
cough does not improve with appropriate
treatment for common causes, a
neuropathic etiology can be considered.
This characteristic symptom complex is
typically longstanding, has trigger
phenomena, is preceded by tickle
sensations in the throat, and produces
paroxysms of unproductive cough.1 Bastian
et al, who proposed these diagnostic
criteria, posit that vagal neuropathy
manifested as laryngeal hypertonicity or
hypersensitivity may be the cause. Some
success has been reported regarding
management with anticonvulsants and
antidepressants as well as botulinum toxin
injections.1-6 However, some cases may be
refractory to such treatments. In this report,
we describe 3 patients diagnosed with
neuropathic cough who had incomplete
response to medical therapy and were
identified as having a trigger at the
cricopharyngeus. All 3 patients underwent
cricopharyngeal myotomy (CPM) with
successful resolution of cough.
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Figure 1. The cricopharyngeus muscle and surrounding structures.
Image from Kelly JH, Management of UES disorders10

Duration of cough
PMH

Case 1
15 years
Sinusitis.

Case 2
21 years
Sinusitis, GERD s/p
fundoplication,
laryngospasm.

10 PY
Increased UES,
increased LES
resting pressures
No evidence of
GERD
Failed Protonix

10 PY
Increased UES,
decreased LES
resting pressures
-

Failed Zyrtec
Failed
Amitriptyline,
nortriptyline,
Lyrica

Failed Advair,
Singulair, Clarinex
Failed
nortriptyline,
gabapentin, and
Lyrica (ADE)

Once
3 times
2009
None

Once
Once
2010
None

METHODS
Smoking Hx
Manometry

A retrospective chart review was
performed for three patients who
underwent cricopharyngeal myotomy for
intractable cough. Trigger phenomena,
previous evaluation and treatment, and
outcomes from their surgery were
assessed and documented. Outcome
measures included use of medication after
surgery and patient perception of
improvement.

RESULTS

CONTACT

DISCUSSION

Table 1 shows the characteristics of
the three cases. All were women aged 6162 who had suffered from unpredictable
paroxysms of non-productive coughing for
15-22 years. Each had also been found to
have an elevated upper esophageal
sphincter pressure on manometry (mean:
184 mmHg, range: 125-219mmHg). None
had obtained lasting relief from cough after
trials of anti-allergy, anti-reflux, and more
traditional therapies. Incomplete or
temporary relief was experienced from
neuropathic medications and esophageal
dilation. Two had experienced temporary
improvement for 6 months after botulinum
toxin injection into the cricopharyngeus.
Subsequent cricopharyngeal myotomy
was performed in all patients. All noted
symptomatic improvement and were
weaned off medication. Continued
improvement was noted at follow up, with a
mean length of 22 months (range: 7-36
months).

pH measurement
Reflux
medication
Allergy
medication
Neuropathic pain
medications

Dilation
Botulinum toxin
Surgery
Meds after
myotomy

Failed Protonix

Case 3
22 years
Sinusitis s/p sinus
surgery, GERD,
asthma, allergies,
laryngospasm.
Never smoked
Increased UES,
decreased LES
resting pressures
No evidence of
GERD
Failed Prilosec
Failed Astelin,
Claritin, Tussionex
Failed
nortriptyline
(ADE), Lyrica,
maintained on
amitriptyline
Once
2012
P.r.n. use of
amitriptyline

Table 1. Characteristics of patients.
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In the majority of patients, systematic evaluation
and optimal therapy will lead to successful resolution of
chronic cough.7 However, in patients for whom thorough
work-up and empirical treatment have not produced a
solution, several models have been described. These
include irritable larynx syndrome, sensory laryngeal
neuropathic cough, and post-viral vagal neuropathy,
which fall under the newly coined umbrella term of
chronic cough hypersensitivity syndrome.8 Just as other
neuropathies may manifest as paralysis or
hypersensitivity to stimuli, vagal neuropathy may
present as dysphonia, dysphagia, paresis, pain,
laryngospasm, or cough. Neuropathy of motor branches
may lead to symptoms of dysphagia and dysphonia
while that of sensory branches produces pain and
decreased cough threshold.
Bastian et al proposed criteria for a sensory
neuropathic model of intractable persistent cough,
including irritable cervical and laryngeal sensations,
severe attacks of non-productive cough that may be
triggered or occur spontaneously, and exclusion criteria
based on psychogenic factors such as secondary gain
and abrupt onset or resolution. Based on this model,
75% of their patients were treated successfully with
amitriptyline.1 By treating paroxysmal chronic cough as
a neuropathic pain disorder, Lee and Woo were able to
achieve symptomatic relief in 68% of patients using
gabapentin, while Van de Kerkhove et al used
gabapentin to decrease cough severity in 20 of 35
patients.3,4 A randomized controlled trial by Ryan et al
showed clinically and statistically significant
improvement with gabapentin in 84% of patients
compared to 40% on placebo; however, cough returned
after cessation of therapy.5 Chu et al attributed the
decreased threshold for cough stimulation and
increased laryngeal tone to hyperexcitable sensory and
motor pathways and aimed to inhibit neurogenic
inflammation and hypertonicity using botulinum toxin
injection of the thyroarytenoid muscles. They reported
complete resolution of cough in a case series of 4
patients.6
In this paper, we report on the use of open
cricopharyngeal myotomy to treat chronic cough. The
rationale behind targeting the cricopharyngeus came
from the observation that these patients identified a
trigger at the approximate level of the cricopharyngeus
and had elevated UES resting pressures on manometry.
Additionally, each had previously obtained improvement
in cough from dilation and/or botulinum toxin injection of
the UES, which can be considered alternatives to
cricopharyngeal myotomy. However, relief was selflimited and therefore cricopharyngeal myotomy was
offered as a possible permanent solution. Notably, all
patients experienced marked improvement. Our
experience with cricopharyngeal myotomy suggests that
successful treatment of neuropathic cough can be
achieved by relieving pharyngeal hypertonicity in select
patients. The recent literature on endoscopic
cricopharyngeal myotomy suggests that the technique
may also be a viable consideration for this population.
However, this would require further study.

CONCLUSION
In conclusion, cricopharyngeal myotomy may be
an alternative treatment for chronic cough in patients for
whom workup is negative and medical management,
dilation, and botulinum toxin have failed to provide longterm relief. However, further study is warranted in this
patient population to support this assertion.

